Tyra Biosciences
TYRA
TYRA
164 hedge funds and large institutions have $2.52B invested in Tyra Biosciences in 2026 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 59 increasing their positions, 35 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
15.93% more ownership
Funds ownership: 106.47% → 122.41% (+16%)
0% more funds holding in top 10
Funds holding in top 10: 12 → 12 (0)
64% less call options, than puts
Call options by funds: $4.2M | Put options by funds: $11.6M
Holders
164
Holding in Top 10
12
Calls
$4.2M
Puts
$11.6M
Top Buyers
| 1 | +$250M | |
| 2 | +$66.5M | |
| 3 | +$49M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$31.5M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$30.9M |
Top Sellers
| 1 | -$85M | |
| 2 | -$76.8M | |
| 3 | -$41.1M | |
| 4 |
CC
Commodore Capital
New York
|
-$29.1M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$27M |
